# Varenicline to Reduce Alcohol Consumption in Heavy Drinkers

> **NCT00695500** · PHASE1,PHASE2 · COMPLETED · sponsor: **Vijay Ramchandani, Ph.D.** · enrollment: 50 (actual)

## Conditions studied

- Alcohol Drinking

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00695500
- **Lead sponsor:** Vijay Ramchandani, Ph.D.
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2014-07
- **Final completion:** 2015-06
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00695500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00695500, "Varenicline to Reduce Alcohol Consumption in Heavy Drinkers". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT00695500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*